Capricor Therapeutics

1 follower

‌

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Biotechnology

Headquarters

Beverly Hills, United States

Employees

11-50

Links

Org chart

Linda Marbán

Chief Executive Officer

Linda Marbán

Collapse

Aj Bergmann

Chief Financial Officer

Kristi A. H. Elliott

Chief Science Officer

Mark Awadalla

Vice President Clinical Research & Development Operations

Yushi Feng

VP of Regulatory Affairs

Jonathan Tayco

Vice President Of Program Management, Operations And Quality

Joe Z.

Senior IP Counsel

Teams

+24

Research and Development

27 members

Leadership Team

3 members

Finance and Accounting

3 members

Similar companies

Immunome

2 followers

Thermo Fisher Scientific

156 followers

GRAIL

27 followers

Cytokinetics

11 followers

Caris Life Sciences

2 followers

BridgeBio

2 followers

Tessera Therapeutics

2 followers

Entrada Therapeutics

1 follower

Scholar Rock

1 follower

Pyxis Oncology

1 follower

Anthropic

51 followers

Explore companies